| Patient | Charles Darwin |
|---|---|
| Date of birth | 1986-02-12 |
| Identifiers | MRN HR-NI003-SYN; SSN (made up) 000-03-2967 |
| Document date | 2026-03-03 |
| Author | Bernard Ashworth, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Recurrent stereotyped episodes of nausea and vomiting for more than a year in a 40-year-old man, about every one to three weeks and almost weekly this winter. Please advise whether this is cyclic vomiting syndrome, whether the work-up is complete, and on prophylaxis, abortive treatment, and an emergency plan. [S]
Urgency: Routine, within six weeks, on the same day as his results visit. [S]
Questions for the consultant:
More than a year of episodes, each beginning with half an hour to an hour of nausea, sweating, trembling hands, a racing heart, and a swimming head, followed by repeated vomiting for 12 to 36 hours; he lies still in a dark room until it passes. Between episodes he has troublesome wind and tires easily but does not vomit. Episodes cluster around social gatherings, speaking to groups, overnight travel, short sleep, and long gaps without food. He has never used cannabis and has no habit of hot baths or showers during episodes. One or two glasses of wine a week; does not smoke. No weight loss, blood in vomit or stool, nocturnal pain, migraine headaches, or neurological symptoms. Past history of palpitations in his twenties. Blood count, electrolytes, creatinine, glucose, calcium, albumin, liver tests, lipase 32 U/L, TSH 1.6, morning cortisol 14.2, tissue transglutaminase IgA 1.2 with total IgA 210, and a urine dipstick all normal, drawn between episodes. ECG: sinus rhythm, QTc 412 ms. GAD-7 8 and PHQ-9 6, with no thoughts of self-harm. CT enterography and upper endoscopy ordered. Blood pressure 118/74 mmHg, pulse 78, weight 71.6 kg, BMI 21.4. No medicines [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
5 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Recurrent episodes of nausea and vomiting over more than a year, with prodromal trembling, palpitations, and dizziness, and flatulence and fatigue between episodes; cause under evaluation | active | confirmed | R11.2 | S — Synthetic presenting concern at the index visit, superseded by the provisional diagnosis at the six-week visit; the episodic vomiting is documented (D). |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| December 1831 | Palpitations and pain about the heart while waiting to sail on the Beagle; no doctor consulted | D (CLM-0003) |
| September 1837 | Palpitations, treated with rest in the country on his doctors' advice | D (CLM-0004) |
| June 1840 | Periodical vomiting, first mentioned in a letter; cause not recorded in the cited source | D (CLM-0005) |
| February 1849 | A winter of dreadful vomiting every week, with trembling hands and a swimming head, and incessant vomiting described in a letter; cause not recorded in the cited source | D (CLM-0006) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-03 | Body height | 183 | cm | S |
| 2026-03-03 | Body weight | 71.6 | kg | S |
| 2026-03-03 | Body mass index (BMI) [Ratio] | 21.4 | kg/m2 | S |
| 2026-03-03 | Systolic blood pressure | 118 | mm[Hg] | S |
| 2026-03-03 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-03-03 | Heart rate | 78 | /min | S |
| 2026-03-03 | Respiratory rate | 14 | /min | S |
| 2026-03-03 | Body temperature | 36.6 | Cel | S |
| 2026-03-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-03 | Hemoglobin [Mass/volume] in Blood | 14.6 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 2026-03-03 | Leukocytes [#/volume] in Blood by Automated count | 6.4 | 10*3/uL | 3.4-9.6 10*3/uL | Normal | S |
| 2026-03-03 | Platelets [#/volume] in Blood by Automated count | 251 | 10*3/uL | 135-317 10*3/uL | Normal | S |
| 2026-03-03 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-03-03 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-03-03 | Chloride [Moles/volume] in Serum or Plasma | 103 | mmol/L | 98-107 mmol/L | Normal | S |
| 2026-03-03 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 25 | mmol/L | 22-29 mmol/L | Normal | S |
| 2026-03-03 | Creatinine [Mass/volume] in Serum or Plasma | 0.94 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-03-03 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 104 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-03-03 | Glucose [Mass/volume] in Serum or Plasma | 88 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-03-03 | Calcium [Mass/volume] in Serum or Plasma | 9.5 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-03-03 | Albumin [Mass/volume] in Serum or Plasma | 4.4 | g/dL | 3.5-5 g/dL | Normal | S |
| 2026-03-03 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 21 | U/L | 7-55 U/L | Normal | S |
| 2026-03-03 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 19 | U/L | 8-48 U/L | Normal | S |
| 2026-03-03 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 68 | U/L | 40-129 U/L | Normal | S |
| 2026-03-03 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.7 | mg/dL | 0.1-1.2 mg/dL | Normal | S |
| 2026-03-03 | Lipase [Enzymatic activity/volume] in Serum or Plasma | 32 | U/L | 13-60 U/L | Normal | S |
| 2026-03-03 | Thyrotropin [Units/volume] in Serum or Plasma | 1.6 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-03-03 | Cortisol [Mass/volume] in Serum or Plasma | 14.2 | ug/dL | 6.2-19.4 ug/dL | Normal | S |
| 2026-03-03 | Tissue transglutaminase IgA Ab [Units/volume] in Serum | 1.2 | U/mL | <=3.9 U/mL | Normal | S |
| 2026-03-03 | IgA [Mass/volume] in Serum or Plasma | 210 | mg/dL | 70-400 mg/dL | Normal | S |
| 2026-03-03 | Q-T interval corrected | 412 | ms | <=450 ms | Normal | S |
| 2026-03-03 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 8 | {score} | S | ||
| 2026-03-03 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S |